These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 7040977)

  • 1. Immunity in cryptococcosis: an overview.
    Fromtling RA; Shadomy HJ
    Mycopathologia; 1982 Mar; 77(3):183-90. PubMed ID: 7040977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-mediated effects against Cryptococcus neoformans: evidence for interdependency and collaboration between humoral and cellular immunity.
    Vecchiarelli A; Casadevall A
    Res Immunol; 1998; 149(4-5):321-33; discussion 500-3. PubMed ID: 9720950
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of cryptococcal antigens on cell-mediated immunity.
    Murphy JW
    Rev Infect Dis; 1988; 10 Suppl 2():S432-5. PubMed ID: 2973118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.
    Diamond RD; May JE; Kane MA; Frank MM; Bennett JE
    J Immunol; 1974 Jun; 112(6):2260-70. PubMed ID: 4596700
    [No Abstract]   [Full Text] [Related]  

  • 5. Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens.
    Pirofski LA
    Trends Microbiol; 2001 Sep; 9(9):445-51. PubMed ID: 11553457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic fractions of Cryptococcus neoformans.
    Graybill JR; Straus DC; Nealon TJ; Hague M; Paque RE
    Mycopathologia; 1982 Apr; 78(1):31-9. PubMed ID: 7048099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated immunity in Cryptococcosis.
    Graybill JR; Alford RH
    Cell Immunol; 1974 Oct; 14(1):12-21. PubMed ID: 4619352
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of antigen-specific suppression by circulating Cryptococcus neoformans antigen.
    Murphy JW; Cox RA
    Clin Exp Immunol; 1988 Aug; 73(2):174-80. PubMed ID: 2460273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of macrophages in immunity and pathogenesis of experimental cryptococcosis induced by the airborne route--Part II: Phagocytosis and intracellular fate of Cryptococcus neoformans.
    Karaoui RM; Hall NK; Larsh HW
    Mykosen; 1977 Nov; 20(11):409-12. PubMed ID: 339078
    [No Abstract]   [Full Text] [Related]  

  • 10. Innate host defenses against Cryptococcus neoformans.
    Hole C; Wormley FL
    J Microbiol; 2016 Mar; 54(3):202-11. PubMed ID: 26920880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-specific immunosuppression by Cryptococcus neoformans infection.
    Blackstock R; Hall NK
    Mycopathologia; 1984 Apr; 86(1):35-43. PubMed ID: 6234468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental cryptococcosis in normal and B-cell-deficient mice.
    Monga DP; Kumar R; Mohapatra LN; Malaviya AN
    Infect Immun; 1979 Oct; 26(1):1-3. PubMed ID: 387600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective cell-mediated immunity against Cryptococcus neoformans.
    Murphy JW
    Res Immunol; 1998; 149(4-5):373-86; discussion 519-22. PubMed ID: 9720955
    [No Abstract]   [Full Text] [Related]  

  • 14. Methodology for Anti-Cryptococcal Vaccine Development.
    Chaturvedi AK; Wormley FL
    Methods Mol Biol; 2017; 1625():129-140. PubMed ID: 28584988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of antibody to capsular polysaccharide in Cryptococcus neoformans infection.
    Feldmesser M; Casadevall A
    Front Biosci; 1998 Feb; 3():d136-51. PubMed ID: 9445465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: a role for nitric oxide.
    Rivera J; Mukherjee J; Weiss LM; Casadevall A
    J Immunol; 2002 Apr; 168(7):3419-27. PubMed ID: 11907100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptococcus neoformans and cryptococcosis.
    Harrison TS
    J Infect; 2000 Jul; 41(1):12-7. PubMed ID: 11041708
    [No Abstract]   [Full Text] [Related]  

  • 18. Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans.
    Beenhouwer DO; Shapiro S; Feldmesser M; Casadevall A; Scharff MD
    Infect Immun; 2001 Oct; 69(10):6445-55. PubMed ID: 11553589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell response to soluble cryptococcal antigens after recovery from cryptococcal infection.
    Hoy JF; Murphy JW; Miller GG
    J Infect Dis; 1989 Jan; 159(1):116-9. PubMed ID: 2462601
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental cryptococcosis in guinea pigs.
    Riera CM; Masih DT; Nobile R
    Mycopathologia; 1983 Jun; 82(3):179-84. PubMed ID: 6350885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.